Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Public ClinicalTrials.gov record NCT06408259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Study identification
- NCT ID
- NCT06408259
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 194 participants
Conditions and interventions
Conditions
Interventions
- Fingolimod Drug
- Ozanimod Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 7, 2025
- Primary completion
- Apr 10, 2031
- Completion
- Jul 12, 2036
- Last update posted
- Apr 27, 2026
2025 – 2036
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0114 | Loma Linda | California | 92354 | Not yet recruiting |
| University of California Davis Health | Sacramento | California | 95817 | Recruiting |
| University of South Florida | Tampa | Florida | 33612 | Recruiting |
| Local Institution - 0093 | Chicago | Illinois | 60611 | Withdrawn |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | Recruiting |
| University of Louisville, Norton Children's Research Institute | Louisville | Kentucky | 40202 | Recruiting |
| Local Institution - 0131 | New Brunswick | New Jersey | 08901 | Not yet recruiting |
| Local Institution - 0132 | Teaneck | New Jersey | 07666 | Withdrawn |
| Local Institution - 0091 | Cincinnati | Ohio | 45229 | Withdrawn |
| Local Institution - 0092 | Portland | Oregon | 97225 | Not yet recruiting |
| Local Institution - 0133 | El Paso | Texas | 79912 | Not yet recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06408259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06408259 live on ClinicalTrials.gov.